Biobank is a type of repository which collects and store biological samples for biomedical research.
Biobank Market Major Players Thermo Fisher Scientific Inc., BioLife Solutions, Inc., Beckman Coulter, Inc., Panasonic Biomedical Sales and Tecan AG. Biobank is a type of repository which collects and store biological samples for biomedical research. The human biological materials include blood, purified DNA, saliva, serum, and other specimens. Preservation of cells and tissues samples is done by cryopreservation at -196 0C or using chemicals. The biobanks keep a health related records of genetic information, lifestyle, and family history. Biobank help researchers to detect human diseases and their unspecified causes by conducting various tests on the samples. Biobanks are largely used to access variety of data representing a large number of people for providing personalized medications, minimizing drug reactions, stem cell research, updating age demographic databases. The biorepositories play a fundamental role in research and development, which is associated with drug development and discovery. Biobanks also provide inevitable assistance in gaining prospective to orphan diseases associated with genome wide studies via single nucleotide polymorphism (SNP). Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/896 Development of personalized medicine to develop effective therapies drives the global biobank market Poor productivity rate of the pharmaceutical industry with 90% failure of proposed drugs during clinical trials, the adherence of human tissue samples, and stem cells to execute pre-clinical trials for reducing high cost associated drug failures are the factors expected to drive the growth of biobank market. Additionally, novelty in cell and tissue disorder treatments, drug discovery, rising incidence of chronic diseases and government initiatives for innovation of regenerative medicines are the key factors driving the global biobank market. The extensive development of personalized treatments by research organizations to develop effective therapies to satisfy medical needs using biological samples is expected to fuel the demand for biobank market during the forecast period. For instance, Illumina signed 4 biobank deals in 2016, with Partners HealthCare, Montreal Heart Institute, University of Colorado and Vanderbilt University with an objective to improve healthcare and develop personalized medicines. However, cost competitive techniques, tissue injury during freezing, reimbursement concerns, lack of standardization, confidentiality and surveillance issues, economic downturn, and ethical issues are the major factors restraining the growth for global biobank market. Report includes chapters which deeply display the following deliverable about industry : • Biobank Market Research Objective and Assumption • Biobank Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Biobank Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Biobank Market, By Regions • Biobank Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Biobank Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Biobank Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Biobank Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Establishment of drug efficacy contributes to the dominance of target tissue segment The global biobank market is segmented on the basis of bio preservation media types, products, analysis, applications, end user and geography. On the basis of bio preservation media types, the global biobank market is segmented into: • Optimized Pre-Formulated Media • Non-Optimized Isotonic Formulation Media On the basis of products, the global biobank market is segmented into: • Consumables • Equipment • Refrigerators and Ice Machines • Liquid Nitrogen Supply Tanks • Cryogenic Storage Systems On the basis of analysis, the global biobank market is segmented into: • Human tissue and tumor cells • Bio-fluids • Stem cells • Umbilical cord • DNA/RNA On the basis of application, the global biobank market is segmented into: • Biobanking • Regenerative Medicine • Drug Discovery On the basis of end-user, the global biobank market is segmented into: • Diagnostic Clinical Centers • Research Organizations • Others Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/896 Increasing funds from National Institute of Health, USA is expected to dominate North America in the global biobank market Regional segmentation of the global biobank market by Coherent Market Insights comprises North America, Latin America, Europe, and Asia-Pacific. According to the research conducted by BioMed Central, United States, stored 270 million specimens in biobanks in 2008, with the rate of new samples collected being 20 million every year. North America is expected to dominate the global biobank market with the increasing funds from healthcare organizations like National Institute of Health (NIH) and National Cancer Institute, which facilitate biobanks across the U.S. Additionally, the rising interest in biotechology has facilitated collaborations of biobanks which is expected to augment the global biobank market in the forecast period. AsiaPacific is expected to have an opportunistic biobank market owing to the rise in diseases, government initiative to finance the cell-based therapies, substantial investment pharmaceutical, high number of biotechnology companies, and public awareness. by Automation of storage processes is the latest trend adopted by the key players Key players operating the global biobank market includes Thermo Fisher Scientific Inc., BioLife Solutions, Inc., Beckman Coulter, Inc., Panasonic Biomedical Sales and Tecan AG. New product launches, increasing collaborations, mergers and acquisitions and partnerships among the market players are some of the strategies observed in global biobanks market. Biomatrica, IntegenX, radiofrequency identification, and micro electromechanical systems are the innovative reagents and products launched for the storage and stabilization of DNA and RNA at room temperature. The other companies operating in the global biobank market are BioCision, Taylor-Wharton International, VWR International and So-Low Environmental Equipment Co. among others. About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]